XML 43 R17.htm IDEA: XBRL DOCUMENT
v3.22.4

Goodwill and Other Intangible Assets | 12 Months Ended
--- | ---
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Other Intangible Assets | GOODWILL AND OTHER INTANGIBLE ASSETS We performed our annual impairment test for goodwill as of October 31, 2022 and determined that the carrying value of the Spine reporting unit exceeded its fair value. As a result an impairment charge of $216 was recognized in the Goodwill impairment line in the Consolidated Statements of Earnings in 2022. As of December 31, 2022 goodwill of the Spine reporting unit is $1,002 after the impairment charge. We estimated the fair value of the Spine reporting unit using a discounted cash flow analysis. Significant inputs to the analysis include assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value, based on the reporting unit’s estimated weighted average cost of capital. The impairment charge for the Spine reporting unit was primarily driven by the slower than anticipated recovery of surgery volumes as we emerge from the COVID-19 pandemic, the competitive pressures in the spine market and rising interest rates in the current macroeconomic environment. For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022. Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.
Changes in the Net Carrying Value of Goodwill by Segment
| MedSurg and Neurotechnology | Orthopaedics and Spine | Total
2020 | $ | 5,459 |  | $ | 7,319 |  | $ | 12,778 |
Additions and adjustments | 223 |  | 59 |  | 282 |
Foreign exchange | (13) |  | (129) |  | (142) |
2021 | $ | 5,669 |  | $ | 7,249 |  | $ | 12,918 |
Goodwill impairment | — |  | (216) |  | (216) |
Additions and adjustments | 2,320 |  | — |  | 2,320 |
Foreign exchange | (54) |  | (88) |  | (142) |
2022 | $ | 7,935 |  | $ | 6,945 |  | $ | 14,880 |
Summary of Other Intangible Assets
| Weighted Average Amortization Period (Years) | Gross Carrying Amount | Less Accumulated Amortization | Net Carrying Amount
Developed technologies
2022 | 14 | $ | 5,440 |  | $ | 2,363 |  | $ | 3,077 |
2021 | 13 | 5,326 |  | 1,956 |  | 3,370 |
Customer relationships
2022 | 15 | $ | 2,847 |  | $ | 1,322 |  | $ | 1,525 |
2021 | 15 | 2,324 |  | 1,174 |  | 1,150 |
Patents
2022 | 11 | $ | 343 |  | $ | 297 |  | $ | 46 |
2021 | 12 | 343 |  | 286 |  | 57 |
Trademarks
2022 | 16 | $ | 425 |  | $ | 220 |  | $ | 205 |
2021 | 16 | 415 |  | 199 |  | 216 |
In-process research and development
2022 | N/A | $ | 21 |  | $ | — |  | $ | 21 |
2021 | N/A | 29 |  | — |  | 29 |
Other
2022 | 6 | $ | 105 |  | $ | 94 |  | $ | 11 |
2021 | 9 | 105 |  | 87 |  | 18 |
Total
2022 | 14 | $ | 9,181 |  | $ | 4,296 |  | $ | 4,885 |
2021 | 14 | 8,542 |  | 3,702 |  | 4,840 |
Estimated Amortization Expense
2023 | 2024 | 2025 | 2026 | 2027
$ | 620 |  | $ | 588 |  | $ | 568 |  | $ | 510 |  | $ | 490 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration